User-friendly HIV Testing and Counseling Services

NCT ID: NCT04585165

Last Updated: 2023-10-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-10-19

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multicenter cohort study of individuals reporting behavioral risks of HIV acquisition, recruited among those presenting for testing for HIV and other sexually transmitted infections.

Overarching goal: to study factors associated with uptake of HIV prevention and (re)testing services in medium-sized cities in Thailand.

Primary objective: To estimate the incidence of HIV and other sexually transmitted infections (syphilis, chronic hepatitis B and C) among individuals presenting for retesting.

Secondary objectives:

* To evaluate the uptake of pre-exposure prophylaxis
* To assess retention in the study
* To evaluate client HIV knowledge
* To describe HIV prevalence and characteristics of individuals newly diagnosed with HIV
* To describe characteristics of individuals at risk of HIV infection
* To assess the quality of the testing and referral services.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Testing and counseling for HIV, syphilis and other sexually transmitted infections is provided to consenting individuals.

Components: interactive counseling program, self sampling (finger prick) under supervision, questionnaire (on a tablet computer) to assess risks of HIV acquisition, understanding of HIV transmission routes and pre-exposure prophylaxis, willingness to take pre-exposure prophylaxis if at risk of HIV, and satisfaction with regard to services provided.

Referral to appropriate care facility of participants diagnosed with infection. HIV negative participants with significant risk of HIV are advised to come back for HIV retesting within 3 to 6 months and informed about pre-exposure prophylaxis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infections Sexually Transmitted Infection Hepatitis B, Chronic Hepatitis C

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Risk of HIV acquisition

Individuals reporting behavioral risk of HIV acquisition.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 15 years or more
* Willing to be tested for HIV and other sexually transmitted infections
* Able to understand the study and its procedures
Minimum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Expertise France-L'Initiative

UNKNOWN

Sponsor Role collaborator

French National Research Institute for Sustainable Development (IRD)

UNKNOWN

Sponsor Role collaborator

Institut de Recherche pour le Developpement

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

GONZAGUE JOURDAIN

Researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gonzague Jourdain, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Chiang Mai University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

STIs Clinic of the Office of Disease Prevention and Control Region 1

Chiang Mai, , Thailand

Site Status RECRUITING

Clinical Service Center, Faculty of Associated Medical Sciences, Chiang Mai University

Chiang Mai, , Thailand

Site Status RECRUITING

MAP Foundation

Chiang Mai, , Thailand

Site Status RECRUITING

Chiang Rai Obstetrics Clinic

Chiang Rai, , Thailand

Site Status RECRUITING

Phayao Hospital

Phayao, , Thailand

Site Status NOT_YET_RECRUITING

University of Phayao Medical Center and Hospital

Phayao, , Thailand

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gonzague Jourdain, MD, PhD

Role: CONTACT

+66 5324 0910

Nicolas Salvadori, PhD

Role: CONTACT

+66 5324 0910

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chonlatorn Boontan, MD

Role: primary

+66 53 276364

Phennapha Klangsinsirikul, PhD

Role: primary

+66 53 949220

Brahm Press

Role: primary

Jullapong Achalapong, MD

Role: primary

66 53 711 300

Guttiga Halue, MD

Role: primary

+66 54 431 209

Sawitree Nangola, PhD

Role: primary

+66 54 466 666

References

Explore related publications, articles, or registry entries linked to this study.

Salvadori N, Decker L, Ngo-Giang-Huong N, Mary JY, Chevret S, Arunothong S, Adam P, Khamduang W, Samleerat T, Luangsook P, Suksa-Ardphasu V, Achalapong J, Rouzioux C, Sirirungsi W, Jourdain G. Impact of Counseling Methods on HIV Retesting Uptake in At-Risk Individuals: A Randomized Controlled Study. AIDS Behav. 2020 May;24(5):1505-1516. doi: 10.1007/s10461-019-02695-2.

Reference Type BACKGROUND
PMID: 31605294 (View on PubMed)

Salvadori N, Adam P, Mary JY, Decker L, Sabin L, Chevret S, Arunothong S, Khamduang W, Luangsook P, Suksa-Ardphasu V, Achalapong J, Rouzioux C, Sirirungsi W, Ngo-Giang-Huong N, Jourdain G. Appointment reminders to increase uptake of HIV retesting by at-risk individuals: a randomized controlled study in Thailand. J Int AIDS Soc. 2020 Apr;23(4):e25478. doi: 10.1002/jia2.25478.

Reference Type BACKGROUND
PMID: 32294318 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://www.napneung.net/

Presentation for potential participants

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Napneung-2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HIV Prevention Among At-risk Latinos in the Heartland
NCT04563715 ENROLLING_BY_INVITATION NA